Drug intelligence / Profile preview

RV4133C

Development stage: Preclinical
Modality: Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

RV4133C is a topical investigational product being studied for the treatment of **facial acne**. It is referenced as "Formula JT2559" in clinical settings, suggesting it is either a novel compound or a new formulation specifically targeting severe comedogenic or inflammatory acne. The **mechanism of action** is not disclosed in public clinical sources, and there is no specific ingredient or pharmacological class referenced. The drug has been used in **3-month treatment phases for subjects with facial acne** in clinical trials[1][7][9]. The developer and manufacturer information is not located in available sources.

Brand names: RV4133CRV-4133CRV 4133C
Other names: RV4133CRV-4133CRV 4133CJT2559JT-2559JT 2559

Beyond the preview

Go deeper on RV4133C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RV4133C.

Explore the full profile